$2.03
1.52% yesterday
Nasdaq, May 20, 09:46 pm CET
ISIN
US0547544033
Symbol
AYTU

Aytu BioScience Inc Stock price

$2.03
+1.00 97.09% 1M
+0.54 36.24% 6M
+0.33 19.41% YTD
-1.05 34.09% 1Y
-9.21 81.95% 3Y
-291.97 99.31% 5Y
-4,791,684.37 100.00% 10Y
Nasdaq, Closing price Tue, May 20 2025
+0.03 1.50%
ISIN
US0547544033
Symbol
AYTU

Key metrics

Market capitalization $12.53m
Enterprise Value $16.88m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.24
P/S ratio (TTM) P/S ratio 0.18
P/B ratio (TTM) P/B ratio 0.36
Revenue growth (TTM) Revenue growth -26.17%
Revenue (TTM) Revenue $69.22m
EBIT (operating result TTM) EBIT $368.00k
Free Cash Flow (TTM) Free Cash Flow $-5.74m
Cash position $18.17m
EPS (TTM) EPS $-0.71
P/E forward 1.95
P/S forward 0.18
EV/Sales forward 0.24
Short interest 3.17%
Show more

Is Aytu BioScience Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

Aytu BioScience Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Aytu BioScience Inc:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Aytu BioScience Inc:

Buy
100%

Financial data from Aytu BioScience Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
69 69
26% 26%
100%
- Direct Costs 26 26
31% 31%
37%
43 43
23% 23%
63%
- Selling and Administrative Expenses 34 34
23% 23%
49%
- Research and Development Expense 2.15 2.15
3% 3%
3%
7.02 7.02
24% 24%
10%
- Depreciation and Amortization 6.66 6.66
14% 14%
10%
EBIT (Operating Income) EBIT 0.37 0.37
75% 75%
1%
Net Profit 1.64 1.64
112% 112%
2%

In millions USD.

Don't miss a Thing! We will send you all news about Aytu BioScience Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Aytu BioScience Inc Stock News

Neutral
Seeking Alpha
6 days ago
Aytu BioPharma, Inc. (Aytu ) Q3 2025 Earnings Conference Call May 14, 2025 4:30 PM ET Company Participants Robert Blum - Investor Relations, Lytham Partners Josh Disbrow - Chief Executive Officer Ryan Selhorn - Chief Financial Officer Conference Call Participants Naz Rahman - Maxim Group Operator Greetings. And welcome to the Aytu BioPharma Fiscal 2025 Q3 Earnings Call.
Neutral
Accesswire
6 days ago
Net income of $4.0 million, or $0.65 and $0.21 net income per share basic and diluted, respectively Adjusted EBITDA1 of $3.9 million Total net revenue of $18.5 million up 32% year-over-year Company to host conference call and webcast today, May 14, 2025, at 4:30 p.m. Eastern time DENVER, CO / ACCESS Newswire / May 14, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharma...
Neutral
Accesswire
13 days ago
DENVER, CO / ACCESS Newswire / May 7, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report its operational and financial results for its third quarter of fiscal 2025, after the market close on Wednesday, May 14, 2025. The Company has scheduled a conference call and webcast that same day, Wednesda...
More Aytu BioScience Inc News

Company Profile

Aytu BioScience, Inc. is a specialty pharmaceutical company, which focuses on identifying, acquiring, and commercializing novel products. Its products include Natesto, Tuzistram, ZolpiMist and MiOXSYS. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.

Head office United States
CEO Joshua Disbrow
Employees 102
Founded 2002
Website www.aytubio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today